AU694103B2 - Novel neutrophil inhibitors - Google Patents

Novel neutrophil inhibitors Download PDF

Info

Publication number
AU694103B2
AU694103B2 AU60805/94A AU6080594A AU694103B2 AU 694103 B2 AU694103 B2 AU 694103B2 AU 60805/94 A AU60805/94 A AU 60805/94A AU 6080594 A AU6080594 A AU 6080594A AU 694103 B2 AU694103 B2 AU 694103B2
Authority
AU
Australia
Prior art keywords
inhibitory factor
neutrophil inhibitory
neutrophil
nif
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU60805/94A
Other languages
English (en)
Other versions
AU6080594A (en
Inventor
David Lee Foster
Matthew Moyle
George Phillip Vlasuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dendreon Pharmaceuticals LLC
Original Assignee
Corvas International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/060,433 external-priority patent/US6756211B1/en
Priority claimed from US08/151,064 external-priority patent/US6962795B1/en
Application filed by Corvas International Inc filed Critical Corvas International Inc
Publication of AU6080594A publication Critical patent/AU6080594A/en
Application granted granted Critical
Publication of AU694103B2 publication Critical patent/AU694103B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU60805/94A 1992-05-11 1993-12-23 Novel neutrophil inhibitors Ceased AU694103B2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US881721 1992-05-11
US99697292A 1992-12-24 1992-12-24
US996972 1992-12-24
US060433 1993-05-11
US08/060,433 US6756211B1 (en) 1992-05-11 1993-05-11 Neutropohil inhibitors
US151064 1993-11-10
US08/151,064 US6962795B1 (en) 1992-05-11 1993-11-10 Neutrophil inhibitors
PCT/US1993/012626 WO1994014973A1 (fr) 1992-12-24 1993-12-23 Nouveaux inhibiteurs de neutrophiles

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU42464/93A Division AU687737B2 (en) 1992-05-11 1993-05-11 Novel neutrophil inhibitors

Publications (2)

Publication Number Publication Date
AU6080594A AU6080594A (en) 1994-07-19
AU694103B2 true AU694103B2 (en) 1998-07-16

Family

ID=27369840

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60805/94A Ceased AU694103B2 (en) 1992-05-11 1993-12-23 Novel neutrophil inhibitors

Country Status (6)

Country Link
EP (1) EP0682714A4 (fr)
JP (1) JPH08505055A (fr)
AU (1) AU694103B2 (fr)
CA (1) CA2152599A1 (fr)
NZ (2) NZ261662A (fr)
WO (1) WO1994014973A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4524816B2 (ja) * 1998-07-06 2010-08-18 東ソー株式会社 Ｉｌ−６レセプター・ｉｌ−６直結融合蛋白質
CN101245110B (zh) * 2007-02-16 2010-09-15 鲁南制药集团股份有限公司 重组中性粒细胞抑制因子和水蛭原嵌合蛋白及其药物组合物
CN115057915B (zh) * 2021-12-28 2024-04-26 四川农业大学 一种大肠杆菌表达蛋白Cry5B在制备抗大熊猫蛔虫成虫和L4期幼虫活性药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338305A (en) * 1975-03-24 1982-07-06 American Home Products Corporation Use of LRH and LRH agonists
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
CA1339101C (fr) * 1986-06-03 1997-07-29 Nicolaas Overbeeke Obtention d'alpha-galactosidase de guar et d'alpha-galactisidase apparente du point de vue immunitaire a l'aide d'organismes hotes transformes par des methodes a adn recombinant

Also Published As

Publication number Publication date
EP0682714A4 (fr) 1997-06-11
JPH08505055A (ja) 1996-06-04
AU6080594A (en) 1994-07-19
EP0682714A1 (fr) 1995-11-22
NZ261662A (en) 1997-03-24
WO1994014973A1 (fr) 1994-07-07
NZ314241A (en) 1999-01-28
CA2152599A1 (fr) 1994-07-07

Similar Documents

Publication Publication Date Title
US6818616B1 (en) Neutrophil inhibitors
Kaumeyer et al. The mRNA for a proteinase inhibitor related to the HI-30 domain of inter-α-trypsin inhibitor also encodes α-1-microgiobulin (protein HC
EP0413908B2 (fr) Fragment extracellulaire soluble du recepteur IFN-bêta 2/IL-6 humain, sa préparation et composition pharmaceutique le contenant
AU780991B2 (en) Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
Ando et al. Molecular cloning, sequencing, and characterization of cDNA for sarcotoxin IIA, an inducible antibacterial protein of Sarcophaga peregrina (flesh fly)
US6706493B2 (en) DNA encoding a cholecystokinin receptor
US20080081901A1 (en) Alpha-conotoxin peptides
US5789178A (en) Neutrophil inhibitors
JPH05501398A (ja) 組換え産生したヒト細胞膜補助因子タンパク（ｍｃｐ）
US5521296A (en) Glycoprotein and gene coding therefor
AU694103B2 (en) Novel neutrophil inhibitors
EP0731709B1 (fr) Des inhibiteurs de neutrophiles provenant des nematodes
US5708141A (en) Neutrophil inhibitors
US20030175881A1 (en) Nucleic acids encoding (poly) peptides having chips activity
NZ516533A (en) Use of neutrophil inhibitors in the manufacture of medicaments to inhibit inflammatory responses and neutrophil activity
EP0724453A1 (fr) Clonage de l'antigene du groupe sanguin de duffy
US6036958A (en) Tsetse thrombin inhibitor
EP1311283A2 (fr) Omega-conopeptides
US20040132663A1 (en) Omega-conopeptides
AU697868C (en) The cloning of Duffy blood group antigen
WO2001018033A1 (fr) Gamma-carboxyglutamate renfermant des conopeptides
AU2005246980A1 (en) Gamma-carboxyglutamate containing conopeptides